XML 170 R60.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended
Oct. 31, 2019
Dec. 31, 2018
Sep. 30, 2016
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Apr. 30, 2020
Sep. 30, 2019
Equity (Details) - Schedule of effect of share-based payment expenses [Line Items]                
Weighted average grant date fair value (in Dollars per share)       $ 14.14        
Percentage of Increase in Annual Dividend 20.00%              
Common Stock, Dividends, Per Share, Declared (in Dollars per share) $ 1.32     $ 1.16 $ 0.91 $ 0.72    
Dividends Payable $ 10.4              
Dividends Payable, Amount Per Share (in Dollars per share) $ 0.33              
Interparfums SA Subsidiary [Member]                
Equity (Details) - Schedule of effect of share-based payment expenses [Line Items]                
Percentage of Increase in Annual Dividend     73.00%          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)   26,600 133,000   26,600     172,851
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost   $ 4.4 $ 3.9          
Number of shares to be distributed into account employee turnover (in Shares)         142,379      
Acquisition, description       During the year ended December 31, 2019, the Company acquired 131,613 shares at an aggregate cost of $5.8 million.        
Subsequent Event [Member]                
Equity (Details) - Schedule of effect of share-based payment expenses [Line Items]                
Dividends Payable, Amount Per Share (in Dollars per share)             $ 0.33  
Equity Option [Member]                
Equity (Details) - Schedule of effect of share-based payment expenses [Line Items]                
Fair value of shares vested       $ 1.4 $ 1.1      
Number of shares available for grant (in Shares)       573,695        
Aggregate intrinsic value of options outstanding       $ 18.7        
Unrecognized compensation cost related to stock options       $ 6.0        
Unrecognized compensation cost, recognition period       5 years        
Weighted average grant date fair value (in Dollars per share)       $ 14.14 $ 14.31 $ 9.82    
Options exercisable, weighted average exercise price (in Dollars per share)       $ 35.05        
Weighted average remaining contractual life of options outstanding, options exercisable       2 years 7 months 13 days        
Aggregate intrinsic value of exercisable options       $ 11.4        
Equity Option [Member] | Minimum [Member]                
Equity (Details) - Schedule of effect of share-based payment expenses [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period       4 years        
Employees [Member] | Interparfums SA Subsidiary [Member]                
Equity (Details) - Schedule of effect of share-based payment expenses [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)     15,100          
Officers And Managers [Member] | Interparfums SA Subsidiary [Member]                
Equity (Details) - Schedule of effect of share-based payment expenses [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)   133,000     133,000